ArticleFrontiers in neuroscience2025
A multi-view multimodal deep learning framework for Alzheimer's disease diagnosis.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- TriFusion-ADFormer: a deep learning framework for early Alzheimer's disease detection using MRI and cognitive metrics.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early diagnosis of Alzheimer's disease (AD) remains challenging due to the high similarity among AD, mild cognitive impairment (MCI), and cognitively normal (CN) individuals, as well as confounding factors such as population heterogeneity, label noise, and variations in imaging acquisition. Although multimodal neuroimaging techniques like MRI and PET can provide complementary information, current approaches are limited in multimodal fusion and multi-scale feature aggregation. Methods: We propose a novel multimodal diagnostic framework, Alzheimer's Disease Multi-View Multimodal Diagnostic Network (ADMV-Net), to enhance recognition accuracy across all AD stages. Specifically, a dual-pathway Hybrid Convolution ResNet module is designed to fuse global semantic and local boundary information, enabling robust three-dimensional medical image feature extraction. Furthermore, a Multi-view Fusion Learning mechanism, which comprises a Global Perception Module, a Multi-level Local Cross-modal Aggregation Network, and a Bidirectional Cross-Attention Module, is introduced to efficiently capture and integrate multimodal features from multiple perspectives. Additionally, a Regional Interest Perception Module is incorporated to highlight brain regions strongly associated with AD pathology. Results: Extensive experiments on public datasets demonstrate that ADMV-Net achieves 94.83% accuracy and 95.97% AUC in AD versus CN classification, significantly outperforming mainstream methods. The framework also shows strong discriminative capability and excellent generalization performance in multi-class classification tasks. Discussion: These findings suggest that ADMV-Net effectively leverages multimodal and multi-view information to improve the diagnostic accuracy of AD. By integrating global, local, and regional features, the framework provides a promising tool for assisting early diagnosis and clinical decision-making in Alzheimer's disease. The implementation code is publicly available at https://github.com/zhaoxinyu-1/ADMV-Net.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.